Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-05

Clinical Trial Update: Levilactobacillus Brevis Oral Health [NA]

View source ↗

Summary

Completed clinical trial evaluating Levilactobacillus brevis for oral health/oral disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levilactobacillus brevis (Levilactobacillus brevis)

Snippet

Sponsor: University of L'Aquila | Conditions: Oral Health, Oral Disease | NA | Status: COMPLETED